Dimensional Fund Advisors LP Raises Position in Henry Schein, Inc. (NASDAQ:HSIC)

Dimensional Fund Advisors LP raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 15.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,137,549 shares of the company's stock after purchasing an additional 279,507 shares during the quarter. Dimensional Fund Advisors LP owned 1.71% of Henry Schein worth $147,920,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of HSIC. Invesco Ltd. lifted its position in Henry Schein by 0.4% in the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after acquiring an additional 17,552 shares in the last quarter. FMR LLC boosted its holdings in Henry Schein by 6.6% during the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock worth $242,064,000 after acquiring an additional 217,143 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Henry Schein by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock worth $218,762,000 after acquiring an additional 14,876 shares in the last quarter. Fiduciary Management Inc. WI raised its holdings in shares of Henry Schein by 7.2% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after purchasing an additional 167,990 shares during the last quarter. Finally, Lyrical Asset Management LP bought a new position in shares of Henry Schein during the fourth quarter valued at about $126,655,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Performance

HSIC traded down $1.19 during trading hours on Wednesday, hitting $64.97. The stock had a trading volume of 1,059,826 shares, compared to its average volume of 1,618,912. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company's fifty day simple moving average is $68.49 and its 200 day simple moving average is $71.68. The stock has a market cap of $7.96 billion, a PE ratio of 26.74, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.66 EPS. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. StockNews.com lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Piper Sandler decreased their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday. UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Finally, Wells Fargo & Company assumed coverage on Henry Schein in a research note on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Henry Schein presently has an average rating of "Moderate Buy" and an average target price of $80.20.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.